Biohit Oyj Series B | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,917.00
1,161.00
2,917.00
3,295.00
6,139.00
2,143
Depreciation, Depletion & Amortization
207.00
231.00
319.00
356.00
1,180.00
1,807
Other Funds
3,225.00
9,991.00
-
-
-
176
Funds from Operations
3,926.00
3,643.00
2,975.00
1,914.00
643.00
144
Changes in Working Capital
517.00
207.00
172.00
543.00
300.00
52
Net Operating Cash Flow
4,443.00
3,436.00
3,147.00
2,457.00
943.00
92
Capital Expenditures
475.00
401.00
223.00
92.00
170.00
Sale of Fixed Assets & Businesses
-
6,826.00
80.00
5.00
1,743.00
Purchase/Sale of Investments
15,108.00
6,516.00
3,034.00
2,609.00
377.00
Net Investing Cash Flow
14,633.00
12,941.00
2,891.00
2,522.00
1,196.00
Cash Dividends Paid - Total
6,792.00
-
-
-
-
Issuance/Reduction of Debt, Net
-
128.00
128.00
128.00
75.00
Net Financing Cash Flow
9,972.00
9,368.00
357.00
128.00
504.00
Net Change in Cash
218.00
141.00
115.00
126.00
742.00
Free Cash Flow
4,918.00
3,837.00
3,370.00
2,549.00
1,113.00
Change in Capital Stock
45.00
751.00
485.00
-
429.00
Exchange Rate Effect
-
4.00
14.00
63.00
15.00
About Biohit Oyj
View Profile
